Healthcare Services Group, Inc. (NASDAQ: HCSG) is drawing attention from investors with its intriguing potential upside of 13.48%, as analysts set an average target price of $24.50. Operating within the..
Progyny, Inc. (NASDAQ: PGNY) has been making waves in the healthcare sector, particularly within the niche of fertility and women’s health benefits solutions. With a market capitalization of $1.78 billion,..
Viridian Therapeutics, Inc. (NASDAQ: VRDN) has garnered attention in the biotech sector, particularly for individual investors seeking high-growth opportunities. With a market capitalization of $2.66 billion, Viridian stands out as..
Acadia Healthcare Company, Inc. (ACHC), a key player in the healthcare sector, specializes in providing essential behavioral healthcare services across the United States and Puerto Rico. With its expansive reach,..
Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the biopharmaceutical sector, is making waves with its focus on developing and commercializing innovative vaccines. With a market capitalization of $1.82..
For investors with an eye on biotech, Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity. Specializing in innovative therapies for retinal diseases and other eye conditions, this Massachusetts-based company..
Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to aesthetic and reconstructive plastic surgery,..
Immunovant, Inc. (NASDAQ: IMVT) is attracting considerable attention in the investment community, particularly among those with an eye for high-reward opportunities in the biotechnology sector. With a market capitalization of..
Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, stands at a pivotal point in its growth trajectory. Specializing in the development of innovative antibody therapeutics, Merus is making waves in..
MannKind Corporation (NASDAQ: MNKD), a key player in the biotechnology sector, is garnering significant attention from investors, thanks to its promising pipeline and substantial growth potential. With a current market..
Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, stands out in the drug manufacturing industry with its focus on over-the-counter health and wellness solutions. Headquartered in..
Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention in the healthcare sector for its innovative focus on hematologic diseases. Headquartered in Watertown, Massachusetts, Disc Medicine is..
NeoGenomics, Inc. (NASDAQ: NEO) stands as a noteworthy contender within the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of $1.47 billion and operating..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) emerges as a compelling opportunity within the healthcare sector, particularly in the high-demand sphere of specialty and generic drug manufacturing. With a market capitalization of..
Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the medical care facilities industry, holds a distinctive position within the healthcare sector. With a market capitalization of $1.87 billion,..
Investors keen on the healthcare sector might find Evotec SE (EVO) an intriguing prospect, particularly given its substantial potential upside of 60.43%. Operating out of Germany, this drug discovery and..
Liquidia Corporation (NASDAQ: LQDA) is capturing investor attention with its impressive 1,121.70% revenue growth, positioning itself as a notable player in the biotechnology sector. Headquartered in Morrisville, North Carolina, Liquidia..
U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specifically in the medical care facilities industry, offers investors a compelling opportunity with a potential upside of..
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company headquartered in South San Francisco, California, is capturing investor attention with a compelling potential upside of 54.09%. As the company..
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at the forefront of innovative biopharmaceutical research, specializing in the discovery and development of cellular metabolism therapies. With a market capitalization of $1.64 billion,..
